Published 1 year ago

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

Summary by News Medical

In a recent prospective study published in the Annals of Internal Medicine Journal, researchers in the United States (US) and Spain performed a randomized controlled trial (RCT) across 127 US hospitals between 2021 and 2022.

0 Articles

All

Left

Center

Right

News Medical

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

1 year ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated1 year agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

0 Articles

0 Articles

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics